Prihantono Prihantono
Overview
Explore the profile of Prihantono Prihantono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamidah H, Rauf S, Arifuddin S, Musba A, Prihantono P, Pelupessy N, et al.
Asian Pac J Cancer Prev
. 2025 Mar;
26(2):625-630.
PMID: 40022710
Objective: The objective of the study is to assess the impact of Spiritual Emotional Freedom Technique (SEFT) intervention on pain severity, cortisol, and IL6 levels in stage III B cervical...
2.
Prihantono P, Jarre S, Raya I, Santi S, Paramita K, Syamsu S, et al.
Asian Pac J Cancer Prev
. 2024 Oct;
25(10):3481-3487.
PMID: 39471014
Objective: Chemotherapy is one of the most effective and widely used treatment types for breast cancer. The Ni(II) proline dithiocarbamate (Ni(II)ProDtc) complex has been synthesized as a potential anticancer agent...
3.
Hasanah U, Ahmad M, Prihantono P, Usman A, Arsyad A, Agustin D
Breast Dis
. 2024 Jun;
43(1):173-185.
PMID: 38875026
Objectives: Research investigating the quality of life (QOL) of breast cancer patients undergoing chemotherapy has yielded useful knowledge regarding the effects of cancer treatment on the quality of life of...
4.
Agussalim N, Ahmad M, Prihantono P, Usman A, Rafiah S, Agustin D
Breast Dis
. 2024 Jun;
43(1):161-171.
PMID: 38875025
Objectives: We reviewed the literature on breast cancer patients' physical activity and quality of life. This paper should urge health services and breast cancer survivors to continue appropriate physical activity...
5.
Sulfiana S, Prihantono P, Usman A, Ahmad M, Aryadi Arsyad M, Agus Mumang A
Breast Dis
. 2024 May;
43(1):127-134.
PMID: 38788058
Introduction: Breast cancer is the most common cancer in women worldwide and is a significant threat to public health. This study aims to conduct a systematic review of the relationship...
6.
Amansyah F, Prihantono P, Hamid F, Syamsu S, Pieter Jr J, Faruk M
Breast Dis
. 2024 Apr;
43(1):71-78.
PMID: 38669518
Background: Molecular subtyping of breast cancer cells is increasingly being developed as an initial step in selecting therapy and predicting the prognosis of breast cancer patients. During breast cancer, the...
7.
Nandana P, Rasyid H, Prihantono P, Yustisia I, Hakim L, Bukhari A, et al.
Asian Pac J Cancer Prev
. 2024 Mar;
25(3):921-930.
PMID: 38546074
Objective: Brucein D (BrD), a quassinoid isolated from Brucea javanica fruit, reportedly demonstrates anti-cancer activity. This study's objective is to evaluate the cytotoxicity of Brucein D and its ability to...
8.
Raya I, Kartina D, Wijaya R, Irfandi R, Abdalrazaq E, Prihantono P, et al.
Asian Pac J Cancer Prev
. 2023 Dec;
24(12):4155-4165.
PMID: 38156851
Objective: Cervical cancer is a malignancy originating from the cervix and often caused by oncogenic Human Papilloma Virus (HPV), specifically subtypes 16 and 18. Anticancer drugs are chemotherapeutic compounds used...
9.
Awaluddin A, Pieter Jr J, Sampepajung E, Syamsu S, Smaradhania N, Hamid F, et al.
Breast Dis
. 2023 Jul;
42(1):191-195.
PMID: 37424456
Background: Breast cancer (BC) is the second most frequent cancer-related death among women worldwide. Factors influencing BC patients' survival include histopathological grade, histopathological type, stage, hormonal receptors, and number of...
10.
Raya I, Kartina D, Irfandi R, Sufiandi S, Wijaya R, Prihantono P, et al.
Breast Dis
. 2023 Jun;
42(1):177-182.
PMID: 37355882
Objective: The new Mg(II) cysteindithiocarbamate complex drug has been synthesized by the in-situ method and tested for its anticancer activity in vitro. Method: Mg(II) cysteindithiocarbamate complexes were characterized using Ultra...